Description
The Semaglutide + Cagrilintide blend provides laboratories with a potent dual-action tool to study complex cellular energy pathways and metabolic kinetics simultaneously.
Key Technical Features
Dual-Action Kinetics: Simultaneously activates GLP-1 and Amylin receptor pathways for comprehensive cellular energy tracking.
Metabolic Research Focus: Designed for studying weight kinetics, glycemic shifts, and appetite regulation mechanisms using this premium Semaglutide + Cagrilintide blend.
Verified Purity: Every batch is tested to guarantee zero degradation and maximum structural integrity. You can review quality standards on our COA Verification Page.
Technical Specifications
| Feature | Details |
| Primary Target | GLP-1 Receptor Agonist + Amylin Receptor Analog |
| Documentation | COA verified peptides status included |
| Category | Metabolic Peptides & Peptide Bioregulators |
| Format | Sterile Lyophilized Powder |
Handling & Storage Guidelines
Storage Condition: Keep the dry vial sealed at -20°C away from direct light exposure.
Reconstitution Protocol: Gently run liquid media down the inside vial wall during reconstitution to prevent peptide chain breakdown. For general laboratory literature and research citations, consult the open access database on PubMed.
Usage Safety: Divide into single-use aliquots post-mixing to completely avoid freeze-thaw cycles.
Research Disclaimer: This product is synthesized strictly for laboratory research and development purposes. It is not intended for human consumption, therapeutic, or diagnostic use.
Reviews
There are no reviews yet.